伊维菌素能预防2019冠状病毒疾病死亡吗？

视频：https://youtu.be/fSL7sqOudoE

When it comes to the treatment of COVID-19,many Western nations have been hobbled by the politicization of medicine.Throughout 2020,media and many public health experts warned against the use of hydroxychloroquine,despite the fact that many practicing doctors were praising its ability to save patients.Many of them were silenced through online censorship.Some even lost their jobs for the"sin"of publicly sharing their successes with the drug.

说到2019冠状病毒疾病的治疗，许多西方国家都被医学的政治化所束缚。整个2020年，媒体和许多公共卫生专家都警告不要使用羟氯喹，尽管许多执业医生都在赞扬它拯救病人的能力。他们中的许多人因为网络审查而沉默。有些人甚至因为公开分享他们的成功而失去了工作。

Another decades-old antiparasitic drug that offers great hope is ivermectin,but it too is being hushed up by mainstream media.Trial Site News¹ tells the story of a 77-year-old Indian couple,both of whom became ill with COVID-19.One successfully recuperated following treatment with hydroxychloroquine.The other with ivermectin.

另一种有几十年历史的抗寄生虫药物是伊维菌素，它给人们带来了巨大的希望，但它也被主流媒体所掩盖。试验网站 News1讲述了一对77岁的印度夫妇的故事，他们都患上了2019冠状病毒疾病。其中一人在接受羟氯喹治疗后成功恢复。另一种是伊维菌素。

While ivermectin certainly appears to be a useful strategy,which is why I am covering it,please understand it is not my primary recommendation.If you are looking at this as a magic bullet,think again.You are far better off first optimizing your vitamin D levels as I have discussed in dozens of previous articles that you can easily find in the search engine at the top of the page.

虽然伊维菌素看起来确实是一个有用的策略，这也是我报道它的原因，但请理解这不是我的主要建议。如果你认为这是一颗神奇的子弹，那么请三思。你最好首先优化你的维生素 d 水平，正如我在以前的几十篇文章中所讨论的，你可以很容易地在页面顶部的搜索引擎中找到。

Remember,you need vitamin D for a wide variety of functions in your body in addition to optimizing your immune response.Although ivermectin is a relatively safe drug,it is still an unnatural synthetic chemical that can have side effects.Vitamin D is something your body absolutely requires for optimal health,which is why I would encourage you to focus on vitamin D first.

记住，除了优化你的免疫反应，你还需要维生素 d 在你身体的各种功能中发挥作用。尽管伊维菌素是一种相对安全的药物，但它仍然是一种非天然的合成化学物质，可能会产生副作用。维生素 d 是你的身体绝对需要的最佳健康状态，这就是为什么我鼓励你首先关注维生素 d。

Inexpensive Treatment Responsible for India's Success?

Getting back to ivermectin,Trial Site News reported² that"Ten months into its battle with the SARS-CoV-2 virus,India is on track to become an unexpected warrior in the fight against this global pandemic.Although the densely-populated nation has four times the population of the U.S.,India has less than half the U.S.COVID deaths."

回到伊维菌素，《试验现场新闻》报道说:"在与 SARS-CoV-2病毒的战斗进行了10个月之后，印度即将成为抗击这一全球性流行病的意想不到的战士。尽管这个人口密集的国家的人口是美国的四倍，但印度的死亡人数还不到美国的一半。"

While India had a daily positive test rate of nearly 100,000 back in September 2020,by the end of December 2020,the infection rate had dropped by 75%.While this rapid decline is by and large being attributed to strict lockdowns,universal mask wearing and extensive contact tracing and testing,the availability and use of effective treatments likely plays a pivotal role.

尽管印度在2020年9月每天的阳性检测率接近10万，但到2020年12月底，感染率下降了75%。虽然这种快速下降大体上归因于严格的封锁、通用口罩的佩戴以及广泛的接触者追踪和测试，但有效治疗的可用性和使用可能起着关键作用。

In late March 2020,India added hydroxychloroquine to its national treatment guidelines,urging the drug be used"as early in the disease course as possible."It was not recommended for those hospitalized with severe illness.

2020年3月下旬，印度在其国家治疗指南中增加了羟氯喹，敦促尽早在疾病过程中使用该药物严重疾病住院的患者不建议使用此药。

Then,in August 2020,India's largest state,Uttar Pradesh,which has some 230 million residents,added ivermectin to its recommendations and distributed the drug for home care free of charge.The state of Bihar,which has 128 million residents,also started recommending ivermectin,and by the end of 2020,Bihar and Uttar Pradesh had the lowest and second-lowest COVID-19 fatality rates in all of India.

然后，在2020年8月，印度最大的邦，拥有2.3亿居民的北方邦，在其建议中增加了伊维菌素，并免费分发了这种药物用于家庭护理。拥有1.28亿居民的比哈尔邦也开始推荐使用伊维菌素，到2020年底，比哈尔邦和北方邦的2019冠状病毒疾病死亡率是全印度倒数第二和最低的。

Uttar Pradesh,however,took it a step further than Bihar.They also used ivermectin as a prophylactic,first among health care workers and then among people who had come in contact with a person who tested positive.

然而，北方邦比比哈尔邦更进一步。他们还使用伊维菌素作为预防药物，首先是在卫生保健工作者中使用，然后是在与检测呈阳性的人有过接触的人中使用。

This drug makes far more sense in India as the vast majority of the population indeed suffer with parasites as a result of largely contaminated municipal water supplies.

这种药物在印度更有意义，因为绝大多数人口确实因为大量污染的城市供水而遭受寄生虫的折磨。

Frontline Doctors Call for Adoption of Ivermectin

视频：https://www.bitchute.com/embed/0MKs9nrfx5Bx/

In the U.S.,the Frontline COVID-19 Critical Care Alliance(FLCCC)is now calling for widespread adoption of Ivermectin,both as a prophylactic and for the treatment of all phases of COVID-19.^3,4

在美国，前线2019冠状病毒疾病危重病护理联盟(FLCCC)现在呼吁广泛采用伊维菌素，既作为预防药物，也作为 COVID-19.3,4各阶段的治疗药物

The data shows the ability of the drug Ivermectin to prevent COVID-19,to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease,and even to help critically ill patients recover.~FLCCC Alliance

数据显示，伊维菌素药物能够预防2019冠状病毒疾病，阻止早期症状发展到疾病的高炎症阶段，甚至帮助危重病人康复。~FLCCC 联盟

December 8,2020,FLCCC president Dr.Pierre Kory,former professor of medicine at St.Luke's Aurora Medical Center in Milwaukee,Wisconsin,testified before the Senate Committee on Homeland Security and Governmental Affairs,where he reviewed the evidence supporting the use of the drug.(He resigned from St.Luke's shortly after giving this testimony,saying the medical center wanted to restrict his freedom of speech.⁵)As noted on the FLCCC website:⁶

2020年12月8日----FLCCC 主席皮埃尔·科里博士，威斯康星州密尔沃基市圣卢克奥罗拉医学中心前医学教授，在参议院国土安全和政府事务委员会前作证，在那里他审查了支持使用该药物的证据。(他在作证后不久就辞去了圣卢克医院的职务，声称医疗中心想要限制他的言论自由。)正如 FLCCC 网站上提到的:

"The data shows the ability of the drug Ivermectin to prevent COVID-19,to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease,and even to help critically ill patients recover.

"数据显示，伊维菌素药物能够预防2019冠状病毒疾病，阻止早期症状发展到疾病的高发期，甚至帮助危重病人康复。

Dr.Kory testified that Ivermectin is effectively a'miracle drug'against COVID-19 and called upon the government's medical authorities—the NIH,CDC,and FDA—to urgently review the latest data and then issue guidelines for physicians,nurse-practitioners,and physician assistants to prescribe Ivermectin for COVID-19."

他呼吁政府的医疗机构----美国国家卫生研究院、美国疾病控制与预防中心和美国食品药品监督管理局----紧急审查最新数据，然后发布指导方针，让医生、护士执业者和医师助理开出伊维菌素治疗2019冠状病毒疾病2019冠状病毒疾病

January 6,2020,Kory and Dr.Paul Marik,chief of pulmonary and critical care medicine at Eastern Virginia Medical School in Norfolk,Virginia—both are founding members of FLCCC—also presented evidence to the National Institutes of Health COVID-19 Treatment Guidelines Panel,which is working to update NIH guidance.⁷ The NIH panel is expected to update treatment guidelines by early February 2021.According to the FLCCC:⁸

2020年1月6日，科里和弗吉尼亚州诺福克市东弗吉尼亚医学院肺病和重症监护医学主任 Paul Marik 博士都是 FLCCC 的创始成员，他们也向美国国立卫生研究院协会2019冠状病毒疾病治疗指南小组提交了证据，该小组正在更新 NIH 的指南。根据 FLCCC 的数据:

"Numerous clinical studies—including peer-reviewed randomized controlled trials—showed large magnitude benefits of Ivermectin in prophylaxis,early treatment and also in late-stage disease.Taken together…dozens of clinical trials that have now emerged from around the world are substantial enough to reliably assess clinical efficacy.

"许多临床研究(包括同行评审的随机对照试验)表明，伊维菌素在预防、早期治疗和晚期疾病方面有巨大的益处。总的来说，现在世界各地出现的几十个临床试验已经足够可靠地评估临床疗效。

Data from 18 randomized controlled trials that included over 2,100 patients…demonstrated that Ivermectin produces faster viral clearance,faster time to hospital discharge,faster time to clinical recovery,and a 75%reduction in mortality rates."

来自18个随机对照试验的数据，包括2100多名患者......证明伊维菌素能够更快地清除病毒，更快地出院，更快地临床恢复，以及将死亡率降低75%。"

A one-page summary⁹ of the clinical trial evidence for Ivermectin can be downloaded from the FLCCC website.A more comprehensive review¹⁰ of trials data has been published in the journal Frontiers of Pharmacology.A listing of all the Ivermectin trials done to date,with links to the published studies,can be found on c19Ivermectin.com.¹¹

伊维菌素临床试验证据的一页摘要可从 FLCCC 网站下载。一个更加全面的试验数据回顾已经发表在药理学前沿杂志上。到目前为止所有伊维菌素试验的清单，以及已发表研究的链接，可以在《c19ivermectin.com 志上找到

How Ivermectin Protects Against COVID-19

Like hydroxychloroquine,ivermectin is an antiparasitic drug with a well-documented safety profile and"proven,highly potent,antiviral and anti-inflammatory properties."¹² It's been on the market since 1981 and is on the World Health Organization's list of essential medicines.It's also inexpensive,with a treatment course costing less than$2 in countries such as India and Bangladesh.¹³

与羟氯喹一样，伊维菌素是一种抗寄生虫药物，其安全性得到了充分证明，并且"被证明具有高效、抗病毒和消炎的特性。"12自1981年以来，这种药物一直在市场上销售，并被列入世界卫生组织的基本药物清单。它也很便宜，在印度和孟加拉国，治疗费用不到2美元。

While the U.S.FDA has not yet approved ivermectin for prevention of or treatment for SARS-CoV-2,¹⁴ studies have shown ivermectin:¹⁵

虽然美国 FDA 尚未批准伊维菌素用于 sars-cov-2的预防或治疗，但已有14项研究表明伊维菌素:

  Inhibits replication of many viruses,including SARS-CoV-2 and seasonal influenza viruses.In"COVID-19:Antiparasitic Offers Treatment Hope,"I review data showing a single dose of ivermectin killed 99.8%of SARS-CoV-2 in 48 hours,"

抑制许多病毒的复制，包括 SARS-CoV-2和季节性流感病毒我回顾数据显示， 2019冠状病毒疾病:抗寄生虫治疗带来希望单剂量伊维菌素在48小时内杀死了99.8%的 SARS-CoV-2

    Inhibits inflammation through several pathways 

通过多种途径抑制炎症

    Lowers viral load 

降低病毒载量

    Protects against organ damage 

保护器官免受损害

    Prevents transmission of SARS-CoV-2 when taken before or after exposure;speeds recovery and lowers risk of hospitalization and death in COVID-19 patients 

在接触之前或之后服用可防止 SARS-CoV-2的传播;加速恢复，降低2019冠状病毒疾病患者住院和死亡的风险

The FLCCC website also has a helpful FAQ section¹⁶ where Kory and Marik answer common questions about the drug and its recommended use.While FLCCC members have been criticized for their insistence that we should not wait for randomized controlled trials before using Ivermectin more widely,the group argues that the drug has a long history of safety and clearly works,so,why wait?

公司网站还有一个很有帮助的常见问题解答部分16，其中科里和马里克回答了有关该药及其推荐使用的常见问题。虽然 FLCCC 成员坚持认为在更广泛地使用伊维菌素之前，我们不应该等待随机对照试验的结果，因此受到了批评，但该组织认为，这种药物具有悠久的安全性和明显的作用，那么，为什么要等待呢？

"If someone...says they want to do an RCT with placebo,that's problematic for me,"Kory told Medpage Today.¹⁷"I could not have a patient admitted to my care and give placebo knowing what I know about Ivermectin."

"如果有人......说他们想用安慰剂做随机对照试验，这对我来说是个问题,"科里告诉《今日医讯》。17"我不能让一个病人在知道我对伊维菌素了解的情况下，接受我的治疗并给予安慰剂。"

One week after Kory and Marik presented their data,the National Institutes of Health updated their stand¹⁸ on use of the drug with a statement that they would not recommend for or against it.The FLCCC quickly followed up with their own statement:¹⁹

在 Kory 和 Marik 公布他们的数据一周后，国立卫生研究院药品管理局更新了他们关于该药物使用的标准，声明他们不会推荐或反对该药物。紧随其后的是他们自己的声明:19

"By no longer recommending against ivermectin use,doctors should feel more open in prescribing ivermectin as another therapeutic option for the treatment of COVID-19.This may clear its path towards FDA emergency use approval."

"不再推荐使用伊维菌素，医生应该更开放地处方伊维菌素作为治疗2019冠状病毒疾病的另一种治疗选择。这可能为 FDA 紧急使用批准扫清了道路。"

WHO's Ivermectin Review

视频：https://youtu.be/yOAh7GtvcOs

While a 75%reduction in mortality is impressive enough(which is the average reduction based on 18 trials according to the FLCCC²⁰),a WHO-sponsored review²¹ suggests ivermectin can reduce COVID-19 mortality by as much as 83%.As reported by Swiss Policy Research:²²

虽然死亡率下降75%已经足够令人印象深刻了(根据 FLCCC20的数据，这是基于18个试验的平均下降幅度)，但世卫组织发起的一项研究表明，伊维菌素可以降低多达83%的2019冠状病毒疾病死亡率。瑞士政策研究报告:22

"This result is based on in-hospital trials,so it does not yet take into account early ambulatory and prophylactic treatment.The authors of the review intend to include three more trials,due to be published sometime in January,before providing a final conclusion."

"这个结果是基于住院试验的，所以它还没有考虑到早期的门诊和预防性治疗。审查报告的作者打算在提供最终结论之前再进行三次试验，这些试验将在一月份的某个时候发表。"

In the video above,Dr.Andrew Hill of the Department of Pharmacology at the University of Liverpool,U.K.,who is leading this review,discusses the preliminary findings.At the end,he too describes ivermectin as a potentially transformative treatment against COVID-19.

在上面的视频中，英国利物浦大学药理学系的安德鲁·希尔博士讨论了初步的研究结果。最后，他也将伊维菌素描述为一种潜在的对抗2019冠状病毒疾病的变革性疗法。

Ivermectin Best as Prophylaxis

While preliminary evidence seems to suggest Ivermectin can be useful at all stages of SARS-CoV-2 infection,its real strength appears to be prophylactic.December 26,2020,Dhaka Tribune²³reported the findings of an observational study²⁴ from Bangladesh,which looked at ivermectin as a pre-exposure prophylaxis for COVID-19 among health care workers.

虽然初步证据似乎表明，伊维菌素可用于 SARS-CoV-2感染的所有阶段，其真正的力量似乎是预防性的。2020年12月26日，达卡论坛报道了来自孟加拉国的一项观察性研究的结果，该研究将伊维菌素视为医护人员的暴露前预防2019冠状病毒疾病。

Fifty-eight volunteers took 12 mg of ivermectin once per month for four months.Only four(6.96%)came down with mild COVID-19 symptoms during the May through August 2020 trial period.In comparison,44 of 60 health care workers(73.3%)who had declined the medication were diagnosed with COVID-19.

58名志愿者连续四个月每月服用一次12毫克伊维菌素。在2020年5月至8月的试验期间，只有4人(6.96%)出现轻微的2019冠状病毒疾病。相比之下，60名拒绝接受药物治疗的医护人员中有44人(73.3%)被诊断为2019冠状病毒疾病。

Both groups worked with COVID-19 positive patients at the Bangladesh Medical College Hospital.Lead researcher Mohammed Tarek Alam told Dhaka Tribune that ivermectin is"apparently very effective as a preventive drug."His team will be seeking permission to conduct a randomized control trial to validate their findings.

这两个小组都在孟加拉医学院医院与2019冠状病毒疾病阳性患者一起工作。首席研究员默罕默德·塔雷克·阿拉姆告诉达卡论坛报，伊维菌素"作为一种预防性药物显然非常有效。"他的团队将寻求许可进行随机控制试验来验证他们的研究结果。

Other Effective Treatment Options

It's worth noting that while the FLCCC is encouraging the use of ivermectin as a prophylactic and early at-home treatment,they also have a more comprehensive early treatment protocol available,as well as an in-hospital protocol.

值得注意的是，虽然 FLCCC 鼓励使用伊维菌素作为预防和早期家庭治疗，他们也有一个更全面的早期治疗方案，以及住院方案。

The treatment protocol was initially dubbed MATH+(an acronym based on the key components of the treatment),but after several tweaks and updates,the prophylaxis and early outpatient treatment protocol is now known as I-MASK+²⁵ while the hospital treatment has been renamed I-MATH+,²⁶due to the addition of the drug ivermectin.

治疗方案最初被称为 MATH+(基于治疗的关键组成部分的缩写)，但经过几次调整和更新，预防和早期门诊治疗方案现在被称为 I-MASK+25，而医院治疗已被重新命名为 i-MATH+，26由于药物伊维菌素的添加。

Vitamin C—which has important antioxidant,anti-inflammatory and immunomodulating effects²⁷—is a central component of this treatment.As noted in a recent landmark review²⁸ on vitamin C for COVID-19,it's common for hospitalized patients to have overt vitamin C deficiency.This is particularly true for older patients and those hospitalized for respiratory infections.

维生素 c 具有重要的抗氧化、抗炎和免疫调节作用，是这种治疗方法的核心成分。正如最近关于2019冠状病毒疾病维生素 c 的里程碑式的评论所指出的那样，住院病人有明显的维生素 c 缺乏症是很常见的。对于老年患者和因呼吸道感染住院的患者尤其如此。

The two protocols(I-MASK+²⁹ and I-MATH+,³⁰)are available for download on the FLCCC website in multiple languages.The clinical and scientific rationale for the I-MATH+hospital protocol has also been peer-reviewed and was published in the Journal of Intensive Care Medicine³¹ in mid-December 2020.

这两个协议(I-MASK+29和 I-MATH+，30)可在 FLCCC 网站上以多种语言下载。临床和科学理论的 I-MATH+医院协议也已经同行评审，并在2020年12月中旬发表在《重症监护医学杂志》上。

Nebulized Peroxide—My Favorite Treatment Choice

视频：https://www.bitchute.com/embed/QoRi6bu3sMEV/




My personal choice for prophylaxis and treatment of COVID-19 symptoms is nebulized peroxide.This is a home remedy I recommend everyone familiarize themselves with,as in many cases it can improve symptoms in mere hours.

我个人选择的预防和治疗2019冠状病毒疾病的症状是雾化过氧化物。这是一个家庭疗法，我建议每个人都熟悉自己，因为在许多情况下，它可以改善症状在短短几个小时。

Nebulizing hydrogen peroxide into your sinuses,throat and lungs is a simple,straightforward way to augment your body's natural expression of hydrogen peroxide to combat infections and can be used both prophylactically after known exposure to COVID-19 and as a treatment for mild,moderate and even severe illness.

将过氧化氢雾化到鼻窦、咽喉和肺部是一种简单、直接的方法，可以增强你身体过氧化氢的自然表达，从而抵抗感染，既可以用于已知暴露于2019冠状病毒疾病的预防性治疗，也可以用于轻度、中度甚至严重疾病的治疗。

Dr.David Brownstein,who has successfully treated over 100 COVID-19 patients with nebulized peroxide,published a case paper³² about this treatment in the July 2020 issue of Science,Public Health Policy and The Law.He also reviews its benefits in"How Nebulized Peroxide Helps Against Respiratory Infections."

医生已经成功地用雾化过氧化物治疗了100多名2019冠状病毒疾病患者，他在2020年7月的《科学》、《公共卫生政策》和《法律》杂志上发表了一篇关于这种治疗的案例论文。他还回顾了它的好处"如何雾化过氧化物有助于对呼吸道感染。"

Nebulized hydrogen peroxide is extremely safe,and all you need is a desktop nebulizer and food-grade hydrogen peroxide,which you'll need to dilute with saline to 0.1%strength.I recommend buying these items beforehand so that you have everything you need and can begin treatment at home at the first signs of a respiratory infection.In the video above,I go over the basics of this treatment.

喷雾过氧化氢是非常安全的，所有你需要的是一个桌面喷雾器和食品级的过氧化氢，你需要与盐水稀释到0.1%的强度。我建议你提前购买这些东西，这样你就有了你需要的一切，一旦出现呼吸道感染的迹象，你就可以在家里开始治疗。在上面的视频中，我讲述了这种治疗的基本原理。

The nebulizer I use is the Pari Trek S Compressor Aerosol System.The large battery option is unnecessary as you can simply plug in the device to run it when you need it.There are likely other nebulizers you can use instead,as long as it plugs into an electrical outlet and doesn't use batteries,as they are low-powered and ineffective nebulizers that don't work as well.

我使用的雾化器是帕里崔克 s 压缩机气溶胶系统。大电池的选择是不必要的，因为你可以简单地插入设备，以运行它当你需要它。可能还有其他的喷雾器可以替代，只要它插在电源插座上，不用电池，因为它们是低功率和无效的喷雾器，不能很好地工作。

来源：

https://articles.mercola.com/sites/articles/archive/2021/01/25/ivermectin-for-coronavirus.aspx?ui=6b1b82089eac4a23f62d506d0428c1d522e57b903b1d7458f117cfdbd83ea51c&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20210125&mid=DM785029&rid=1067758545